BCR::ABL1-like acute lymphoblastic leukaemia: a single institution experience on identification of potentially therapeutic targetable cases

BACKGROUND: BCR::ABL1-like acute lymphoblastic leukaemia (BCR::ABL1-like ALL) is characterized by inferior outcomes. Current efforts concentrate on the identification of molecular targets to improve the therapy results. The accessibility to next generation sequencing, a recommended diagnostic method...

Descripción completa

Detalles Bibliográficos
Autores principales: Płotka, Anna, Przybyłowicz-Chalecka, Anna, Korolczuk, Maria, Kanduła, Zuzanna, Ratajczak, Błażej, Kiernicka-Parulska, Jolanta, Mierzwa, Anna, Godziewska, Katarzyna, Jarmuż-Szymczak, Małgorzata, Gil, Lidia, Lewandowski, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318696/
https://www.ncbi.nlm.nih.gov/pubmed/37400842
http://dx.doi.org/10.1186/s13039-023-00645-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318696/
https://www.ncbi.nlm.nih.gov/pubmed/37400842
http://dx.doi.org/10.1186/s13039-023-00645-1

Ejemplares similares